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The signal peptides of most proteins targeted to the endoplasmic reticulum are specifically cleaved by signal peptidase. 
Although potential c eavage sites occur frequentJy inpolytopic proteins after membrane-spanning segments, processing 
is restricted tothe first hydrophobic domain, suggesting that signal peptidase might not have access to subsequently trans- 
located, internal domains. To test his hypothesis, we replaced the third transmembrane segment ofan artificial threefold 
membrane-spanning protein by a sequence which is normally an amino-terminal signal. Upon in vitro translation and 
insertion into microsomes, fficient cleavage atthis sequence was observed, thus demonstrating the ability of signal pep- 
tidase to cleave within polytopic membrane proteins. 
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1. INTRODUCTION 
In eukaryotic cells, most secretory and mem- 
brane proteins are targeted to the endoplasmic 
reticulum (ER) by amino-terminal signal peptides 
of typically 16-26 residues [1,2]. They contain a 
characteristic stretch of 8-12 apolar residues and 
are recognized by signal recognition particle (SRP) 
[3]. SRP in combination with its receptor in the ER 
membrane is responsible for directing the transla- 
tion complex to the correct organeUe. As 
translocation of the polypeptide across the mem- 
brane is initiated, the signal peptide interacts with 
a transmembrane protein termed the signal se- 
quence receptor [4], presumed to be a component 
of the translocation machinery. Finally, most 
signal peptides are proteolytically removed from 
the nascent polypeptide by a highly specific en- 
doprotease on the luminal side of the ER 
membrane. 
The high specificity of this signal peptidase con- 
trasts with the diversity of sequences found at the 
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sites of signal peptide cleavage. The enzyme was 
shown to have a strong preference for small un- 
charged residues at positions -1  and -3  with 
respect to the cleaved peptide bond [1,5,6]. 
Statistical analysis of known secretory and mem- 
brane proteins revealed an additional but weaker 
bias for certain groups of amino acids at adjacent 
positions and a preferred proximity of the cleavage 
site to the hydrophobic domain of the signal se- 
quence [1,7]. Based on these statistical data, an 
algorithm has been developed by Von Heijne [7] to 
calculate the most probable processing sites in a 
protein with a success rate of 75-80°7o. Whether or 
not a sequence is cleaved, however, cannot be 
predicted by this method. Within the sequences of 
membrane proteins, for example, sites with 'high 
processing probability' are found after almost 
every membrane-spanning domain. Transmem- 
brane segments which have their carboxy-terminal 
end exposed to the ER lumen are potential 
substrates for signal peptidase. In two cases of 
uncleaved, internal signal sequences of type II 
membrane proteins (amino-terminus cytoplasmic, 
carboxy-terminus exoplasmic) [8] it has been 
shown that cryptic cleavage sites could be 'ac- 
tivated' by changing the cytoplasmic flanking se- 
quences [9,10]. What features contribute to the 
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specificity of  signal peptidase, however, is not 
completely understood. 
Signal peptidase was found to be associated in a 
complex of  several proteins suspected of  being 
directly or indirectly related to protein transloca- 
t ion [11,12]. A close association with the transloca- 
t ion machinery is also consistent with the not ion 
that signal cleavage occurs co-translationally [13]. 
In all natural and artificial proteins analyzed, 
cleavage is restricted to the first hydrophobic do- 
main inserted into the membrane.  A simple ex- 
planat ion could be that the enzyme has no access 
to subsequently inserted membrane-spanning do- 
mains. Here, we have tested the ability of  signal 
peptidase to cleave also inside a polytopic mem- 
brane protein by inserting a normal ly cleaved 
signal sequence in place of  the third potential 
t ransmembrane domain.  
2. MATERIALS  AND METHODS 
2.1. Materials 
SP6 RNA polymerase and endo-~-N-acetylglucosaminidase 
H (Endo H) were ptlrchased from Boehringer, Mannheim. 
Other modifying and restriction enzymes and linkers were pur- 
chased from Boehringer and New England Biolabs. Proteinase 
K was purchased from Sigma; RNase inhibitor from Promega 
Biotech; and protein A-Sepharose from Pharmacia. 
2.2. Plasmid construction 
Standard techniques were used for DNA manipulations [14]. 
The plasmid pSAAA, which has been described earlier [15], was 
linearized with ClaI upstream of the sequence ncoding the 
third transmembrane segment, digested with exonuclease Bal31, 
and provided with ClaI linkers (CATCGATG). In one of the 
resulting plasmids, pB5, 155 bp have been deleted upstream of 
the original ClaI site. The plasmid pSB6 corresponds to the 
wild-type cDNA of ASGP receptor H1 (gSA1) [16] in which 
nucleotides 267-283 had been deleted by Bal31 digestion and 
replaced by a ClaI linker. The sequence upstream of the ClaI 
site of pB5 was ligated to the sequence downstream of the ClaI 
site of pSB6 to yield pSAAA50. In summary, the recombinant 
DNA encodes the following protein sequence (amino acids 
generated by linker sequences are indicated in single-letter 
code): residues 1-156 of HI, RC, 38-104 of H1, PSM, 38-291 
of HI. 
To construct pSAAH50, the plasmid pSNHC (containing the 
cDNA of the ASGP receptor HI in which the transmembrane 
segment had been replaced by the signal sequence of influenza 
virus hemagglutinin [10]) was linearized at the NruI site 
preceding the hemagglutinin segment, and a SalI(AccI) linker 
(CCGGTCGACCGG) linker was inserted. The sequence 
downstream of the new Accl site of this plasmid was ligated to 
the sequence upstream of the ClaI site of pB5. The resulting 
plasmid pSAAH50 encodes the following protein sequence: 
residues 1-156 of H1, RC, 38-104 of HI, PSTGD, 2-18 of 
hemagglutinin, R 60-291 of HI. 
2.3. In vitro transcription and translation 
For in vitro transcription, 2/zg of plasmid DNA linearized 
with EcoRI were incubated in 40 mM Tris-HC1, pH 7.5, 6 mM 
MgCI2, 2 mM spermidine, 0.5 mM each of ATP, CTP, GTP, 
UTP, and the cap analogue 7m GpppG, 10 mM dithiothreitol, 
50 U RNase inhibitor, and 20 U of SP6 RNA polymerase, ina 
total volume of 50 #1 for 1 h at 40°C. Nucleic acids (containing 
approx. 2-3/zg of RNA) were then precipitated with ethanol 
and redissolved in 25/zl H20. 
Translation was performed using rabbit reticulocyte lysate as 
described by Pelham and Jackson [17] for 1 h at 30°C using 1/A 
(approx. 100 ng) of RNA in a standard 25/zl reaction, with or 
without 1/zl of dog pancreas microsomes (isolated and column- 
washed according to Walter and Blobel [18]). Protease protec- 
tion was assayed by incubating the samples on ice for 20 min 
with 50 #g/ml proteinase K in the absence or presence of 0.5% 
Nonidet P-40. Digestion was terminated by addition of 100/zl 
of phosphate-buffered saline (PBS, 12.5 mM Na-phosphate, 
pH 7.5, 125 mM NaCI) containing 2mM phenylmethylsulfonyl 
fluoride (PMSF). After addition of 500/~1 PBS containing 1% 
Triton X-100, 0.5°70 deoxycholate, 0.5% SDS, 1 mM PMSF, 
1 mg/ml bovine serum albumin, the samples were split in half 
and immunoprecipitated using antiserum raised against isolated 
human ASGP receptor and antiserum against a synthetic pep- 
tide, GCETELDKASQE, which (except for the amino-terminal 
glycine) corresponds to residues 277-287 at the carboxy- 
terminus of the ASGP receptor HI. The immune complexes 
were isolated with protein A-Sepharose (15 ,ul per sample) and 
released by boiling for 2 min in 100/~1 of 50 mM Na-citrate, pH 
6, 1% SDS. Some of the samples were deglycosylated by in- 
cubation with 3 mU of Endo H for 1 h at 37°C. Finally, all 
samples were boiled in SDS-sample buffer and analyzed by 15% 
SDS-polyacrylamide g lelectrophoresis [19]. The gels were fix- 
ed, soaked in 1 M Na-salicylate containing 1~70 glycerol, dried 
and fluorographed on Kodak XAR-5 film for 1-2 days at 
- 70°C. 
3. RESULTS 
The human asialoglycoprotein (ASGP) receptor 
H1 is a membrane protein containing a single 
hydrophobic  segment of  approx. 20 apolar amino 
acids that functions both as an internal, uncleaved 
signal sequence and as a t ransmembrane anchor of  
the mature protein [16,20,21] (schematically 
shown in f ig . lA ,  pSA1). Previously we have 
described the construction of  an artificial 
polytopic membrane protein on the cDNA level by 
repeating the signal-anchor domain as well as the 
adjacent sites for N-l inked glycosylation three 
times [15]. Upon in vitro translation in the 
presence of  microsomes, this protein was inserted 
sequential ly into the target membranes: the first 
hydrophobic  domain functioned as a signal and 
the second as a stop-transfer sequence, while the 
third initiated a second translocation process [15] 
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Fig. 1. Summary of the membrane protein constructs. (A) The polypeptides ncoded by the cDNA constructs are shown schematically. 
Sequences derived from the ASGP receptor HI are shown as open bars with the hydrophobic domains tippled and the potential 
glycosylation sites indicated as diamonds. The sequence derived from influenza virus hemagglutinin s shown in black with the 
hydrophobic segment striped. An arrow points at the potential cleavage site. (B and C) Schematic representation f the expected 
topologies of the proteins encoded by the plasmids pSAAA50 (B) and pSAAH50 (C) in the microsomal membrane before and after 
digestion with exogenous protease. Potential sites for N-linked glycosylation are shown as diamonds; the ones that are actually used 
are shown in black. Signal peptidase cleavage is indicated by arrows. (Whether the internalized signal of hemagglutinin remains 
associated with the membrane after cleavage is not known.) 
(illustrated in fig. 1B). The topology of the transla- 
tion products could be deduced from their 
glycosylation patterns and from the sizes of the 
peptide fragments resistant to exogenous protease. 
To test the ability of signal peptidase to cleave 
inside a polytopic membrane protein, we exchang- 
ed the third copy of the signal-anchor sequence by 
the normally amino-terminal, c eavable signal se- 
quence of influenza virus hemagglutinin (fig.lA). 
If signal cleavage occurs in this internal position, 
the polypeptide will be cut into two fragments 
upon membrane insertion (fig.lC). Because the 
fragments expected by cleavage at the third 
transmembrane segment would be very similar in 
size, a variant of the original threefold membrane- 
spanning construct pSAAA [15] was used for this 
study. In pSAAA50 the hydrophilic segment be- 
tween the second and the third hydrophobic do- 
main is shortened to 50 residues. Replacement of
the third signal-anchor domain the hemagglutinin 
signal sequence resulted in pSAAH50. 
Translation of mRNA transcribed from the 
plasmid pSAAA50 is analyzed in fig.2. The 
translation products were immunoprecipitated 
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Fig.2. In vitro translation and membrane insertion of pSAAA50. RNA derived from the plasmid pSAAA50 was translated in a 
reticulocyte lysate system in the absence ( - )  or presence (M) of microsomes. The products were immunoprecipitated either with a 
polyclonal antiserum raised against he isolated human ASGP receptor (A) or with an antiserum raised against an oligopeptide 
corresponding to the carboxy-terminus of the protein (B). Fluorographs after SDS-polyacrylamide gel electrophoresis are shown. 
Abbreviations: M, microsomes present during translation; K, posttranslational incubation with proteinase K; D, detergent NP-40 
present during incubation with proteinase K; H, Endo H digestion of the final products. The position of marker proteins and their 
molecular masses inkDa are indicated. The different glycosylated products are indicated by dots (carboxy-terminal polypeptides) and 
triangles. 
either by an antiserum raised against he isolated 
ASGP receptor (panel A), or by an antiserum 
directed against a synthetic peptide corresponding 
to the carboxy-terminus of the protein (panel B). 
In the absence of membranes a polypeptide of ap- 
prox. 50 kDa was synthesized (fig.2, lanes 1 and 
8), which was completely sensitive to proteinase K 
(lanes 2 and 9). I f  translation was performed in the 
presence of dog pancreas microsomes, the majori- 
ty of the products were glycosylated (lanes 3 and 
10). It has been shown previously that each 
oligosaccharide transferred to the polypeptide 
results in an increase of the apparent molecular 
mass of approx. 3 kDa [15], which is reversed 
upon deglycosylation with endo-fl-N-acetyl- 
glucosaminidase H (Endo H; lanes 4 and 11). Most 
of the products were threefold glycosylated, in- 
dicative of the threefold membrane-spanning 
topology illustrated in fig. 1B: one oligosaccharide 
was transferred to the translocated ' loop' segment 
(the second potential glycosylation site is located 
too close to the membrane surface to be accessible 
to the oligosaccharide transferase [15]), and two to 
the translocated 'tail' segment. Only a small frac- 
tion of the polypeptides had not performed the 
second translocation step and was thus glyco- 
sylated only once. 
The threefold membrane-spanning structure of 
the protein is confirmed by the size and glycosyla- 
tion of the fragments resistant to posttranslational 
protease digestion. The larger twice-glycosylated 
one of approx. 38 kDa corresponds to the tail 
because it was precipitated by both the anti- 
receptor antiserum and the antiserum specific for 
the carboxy-terminal oligopeptide. The smaller 
fragment was glycosylated once, was recognized 
only by the anti-receptor antiserum, and thus cor- 
responds to the loop (lanes 5, 6, 12 and 13). 
Disruption of the membranes by detergent resulted 
in complete digestion of the translation products 
by proteinase K (lanes 7 and 14). 
Translation of mRNA transcribed from 
pSAAH50, in which the signal sequence of hemag- 
glutinin serves as the third hydrophobic domain, 
also produced a protein of 50 kDa (fig.3, lanes 1 
and 8). In the presence of microsomes, however, 
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Fig.3. In vitro translation and membrane insertion of pSAAHS0 containing an internalized hemagglutinin signal sequence. RNA 
derived from the plasmid pSAAHS0 was translated and the products were analyzed as described in the legend to fig.2, using an 
antiserum against otal ASGP receptor (A) and an antiserum specific for the carboxy-terminus of the protein (B). The abbreviations 
are the same as in fig.2. Open triangles point at the small amount of amino-terminal fragments hat are coprecipitated with the carboxy- 
terminal fragments in lanes 10 and l l .  
the only full-size products synthesized are either 
not glycosylated at all and are therefore most likely 
not inserted into the microsomes, or carry only one 
oligosaccharide and correspond to polypeptides 
that have performed only the first translocation 
step (see fig. 1C). No threefold glycosylated protein 
was detectable (fig.3, lanes 3 and 10). Instead two 
fragments were generated. The larger one of ap- 
prox. 38 kDa was glycosylated twice (lanes 3 and 
4, dots), completely resistant o exogenous pro- 
tease (lanes 5 and 6), and corresponds to 
translocated tail fragments, since it is efficiently 
immunoprecipitated by the antiserum against he 
carboxy-terminal oligopeptide (fig.3B). The 
smaller fragment was glycosylated once (lanes 3 
and 4, triangles) and is only partially resistant o 
exogenous protease (lanes 5 and 6). It thus cor- 
responds to the amino-terminal half of the protein 
that is partly exposed on the outside of the 
microsomes. Surprisingly, approx. 40°/0 of this 
fragment (as determined by densitometric s anning 
of the fluorograph) is co-precipitated by the an- 
tiserum against he carboxy-terminal peptide (lanes 
10 and 11, open triangles), suggesting that some of 
the cleavage products remained noncovalently 
associated with one another. This interaction 
might be similar to that responsible for the 
oligomerization of the wild-type ASGP receptor 
HI to dimers and trimers [22]. Upon protease 
digestion of the microsomes (lanes 12 and 13), no 
association of the two fragments is detectable. 
4. DISCUSSION 
Previously it has been shown that signal peptides 
do not have to be exposed at the very amino- 
terminus to be a substrate of signal peptidase: nor- 
mal amino-terminal signal sequences in an internal 
position, preceded by up to more than 100 amino 
acids, were still found to be efficiently cleaved 
[10,23,24]. However, the hemagglutinin signal se- 
quence was not cleaved when, as part of a 
translocating polypeptide, it was transported 
through the membrane with the inverted orienta- 
tion (amino to carboxy-terminus) with respect o 
that of cleaved signal sequences [25]. 
In this work, we have demonstrated that signal 
cleavage is not restricted to the first insertion se- 
quence in a protein, but that signal peptidase can 
also act on a cleavable sequence inside a polytopic 
97 
Volume 253, number 1,2 FEBS LETTERS August 1989 
membrane protein provided it is located on the 
luminal side of a membrane-spanning domain. The 
normally cleaved signal of influenza virus hemag- 
glutinin inserted ownstream of a first (uncleaved) 
signal and a stop-transfer sequence (two copies of 
the signal-anchor sequence of the ASGP receptor 
H 1) is efficiently cleaved as it functions as a secon- 
dary insertion sequence. According to all available 
criteria, this processing is due to the ER signal pep- 
tidase: it does not occur in the absence of 
microsomes; it is restricted to polypeptides that are 
inserted into the microsomes and that have per- 
formed the second translocation process; and it is 
specific for the protein containing the hemag- 
glutinin signal sequence. 
The length of the hydrophilic segment between 
the second hydrophobic domain (the stop-transfer 
sequence) and the third (the second insertion 
signal) in our constructs i 50 residues well within 
the range found in natural multi-spanning pro- 
teins. Based on their predicted membrane 
topology, naturally occurring cytoplasmic loops 
contain from less than 5 to more than 100 amino 
acids. It is therefore likely that our findings also 
apply to natural polytopic membrane proteins. 
Signal peptidase is thus not specific for the first in- 
sertion sequence in a membrane protein. 
According to our present knowledge the high 
specificity of signal peptidase is based on the 
primary sequence near the actual cleavage site, 
whereby the consensus for this sequence is very 
limited. Furthermore, there is evidence that the 
subtle positioning of a potentially cleavable se- 
quence close to the exoplasmic surface of the ER 
membrane is a structural requirement for process- 
ing: deletion of the amino-terminal domains 
preceding the normally uncleaved, internal signals 
of the invariant chain of the HLA-DR histocom- 
patibility antigen [9] and of the ASGP receptor H 1 
[10] resulted in cleavage at cryptic sites that are not 
accessible or not recognized in the wild-type pro- 
teins. If these are indeed the only determinants of
signal peptidase activity, an evolutionary pressure 
must exist against he formation of cleavable sites 
on the exoplasmic side of transmembrane segments 
in membrane proteins. 
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